WPRIM Management System> DCMS> Journal of Experimental Hematology> 2008> 16> 1

Volume: 16 Issue: 1

1. Advances of study on culture and inductive differentiation of human embryonic stem cells and its problems. Page:227—230
2. Reconstitution kinetics of dendritic cells following allogeneic hematopoietic stem cell transplantation. Page:222—226
3. Research advance on molecular genetics of CML blast crisis. Page:217—221
4. An update on beta2 integrin LFA-1 and ligand ICAM-1 signaling. Page:213—216
5. Main regulatory factors for differentiation, development and function of naturally occurred CD4+ CD25+ regulatory T cells. Page:207—212
6. Allogeneic peripheral blood hematopoietic stem cell transplantation for post-operatively treating acute non-lymphocytic leukemia patient complicated with renal cell carcinoma: one case report. Page:203—206
7. Clinical analysis of 23 patients with primary non-Hodgkin's lymphoma originated in bone. Page:200—202
8. Plasma suPAR level in patients with multiple myeloma. Page:197—199
9. Therapy of 17 cases of idiopathic thrombocytopenia purpura by amifostine. Page:192—196
10. Effectiveness of bacterial screening in preventing and controlling platelet bacterial contamination. Page:189—191
11. Establishment of genotyping method for human platelet antigens of HPA-15 system by PCR-SSP. Page:185—188
12. Expression of fusion protein encoding EGFP-EGF1 of rat coagulation factor VII and its binding function. Page:181—184
13. Brain derived neurotrophic factor induces endothelial cells angiogenesis through AKT and ERK1/2 signal pathway. Page:175—180
14. Inhibitory Effect of CCL20 on CD4+ CD25+ regulatory T cell development in mouse thymus. Page:170—174
15. Foxp3-transfected CD4+ CD25- T cells suppress function of dendritic cells. Page:164—169
16. Hematopoiesis is normally maintained in osteoblast-specific Smad4 gene knockout mice. Page:159—163
17. Effect of co-culture of bone marrow mesenchymal stem cells and K562 cells on expression of interleukin 8. Page:156—158
18. Effect of low dose radiation on human corrected bone marrow mesenchymal stem cells by using proteomic analysis. Page:151—155
19. Experimental study on human bone marrow mesenchymal stem cells transfected by SDF-1 cDNA. Page:147—150
20. Comparative characterization of mesenchymal stem cells from human umbilical cord tissue and bone marrow. Page:140—146
21. Relationship between Clostridium difficile associated diarrhea and intestinal microecosystem disorder in patients received allogeneic hematopoietic stem cell transplantation. Page:135—139
22. Tandem double autologous peripheral blood stem cell transplants for de novo multiple myeloma. Page:131—134
23. Effect of recipient mouse splenocytes taken orally by donor mouse on GVHD after splenocyte transplantation. Page:126—130
24. Expanding capacity of mesenchymal stem cells from patients after hematopoietic stem cell transplantation. Page:120—125
25. Acute graft versus host disease in non-myeloablative allogeneic stem cell transplantation. Page:116—119
26. Impact of donor KIR2DS5 genotype on outcome following haploidentical hematopoietic stem cell transplantation. Page:111—115
27. Population pharmacokinetics of high-dose methotrexate administered in 329 children with acute lymphoblastic leukemia. Page:106—110
28. Clinical investigation on treatment of children leukemia with non-T-cell depleted haploidentical bone marrow transplantation. Page:101—105
29. Association of gene polymorphisms in the DNA repair gene XPD with risk of non-Hodgkin's lymphoma. Page:97—100
30. Effects of matrine on the apoptosis and expression of adhesion molecule in multiple myeloma RMPI8226 cells. Page:93—96
31. Effect of phenylhexyl isothiocyanate on inducing apoptosis of multiple myeloma cells in vitro. Page:89—92
32. Effect of arsenic trioxide combined with bortezomib on proliferation, apoptosis and beta-catenin level in myeloma cell lines. Page:84—88
33. Osteoblasts from patients with myelodysplastic syndrome express multiple cytokines and support hematopoietic progenitor cell survival in vitro. Page:78—83
34. Efficacy of diacetyl hexamethylene diamine in treatment of patients with high risk myelodysplastic syndrome. Page:74—77
35. Methylation status of ZO-1 gene in patients with myelodysplastic syndrome. Page:70—73
36. Influence of tetrandrine on SORCIN gene expression in K562/A02 cell line. Page:65—69
37. Effect of tetrandrine, toremifene and their combination on the reversion of multidrug resistance of K562/A02 cell line. Page:61—64
38. Plasmid-mediated RNAi targeting hTERT inhibits telomerase activity in K562 cell line. Page:54—60
39. Effect of antisense oligodeoxynucleotide targeting hTERT on telomerase activity and cell apoptosis in K562 cell line. Page:48—53
40. cAMP analogue 8-CPT-cAMP inducing differentiation in the M2b subtype of acute myeloid leukemia cell line Kasumi-1. Page:44—47
41. Inhibitory effect of genistein on hypoxia-inducible factor-1alpha expression induced by cobalt chloride in leukemia cell line K562. Page:38—43
42. Expression of anti-apoptosis livin gene in acute non-lymphocytic leukemia cells and its clinical significance. Page:35—37
43. Gene expression of breast cancer resistance protein in adult acute lymphocytic leukemia and its clinical significance. Page:31—34
44. Polymorphisms of CYP3A5 gene in acute leukemia patients and their role in chemotherapy and prognosis. Page:26—30
45. Characteristics of cases with chromosome 3q21q26 aberrations. Page:22—25
46. Experimental hematology bridging the gap between laboratory and clinic: hope of hematology. Page:1—21